Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Terranueva Gets an Additional $500,000 in Financial Support From Canada Economic Development

C.TEQ

L’ASSOMPTION, Quebec, April 07, 2021 (GLOBE NEWSWIRE) -- Terranueva Corporation (CSE : TEQ) (the “ Corporation ” or “ Terranueva ”), one of the 6 companies in Québec holding a licence from Health Canada to develop cannabis products for medical and recreational purposes, is pleased to announce that Canada Economic Development (“ CED ”) has granted the Corporation a $500,000 loan to the business to support its day-to-day operations, bringing CED’s support to the Corporation to $1 million to date.

This assistance from CED comes from the Regional Relief and Recovery Fund (“ RRRF ”), which is part of Canada’s COVID-19 Economic Response Plan.

“Following the conclusion of the recent private placement, by injecting another $500,000 into our working capital, CED is allowing us to continue executing our strategic plan, particularly by supporting our research and development activities, by allowing us to continue producing our harvests in our MPU (modular production unit) and the development of innovative products,” underlines Peter Polatos, President and CEO of Terranueva.

ABOUT TERRANUEVA

Terranueva relies on research and development, innovation and operational efficiency to become a key player in the emerging cannabis industry. It aims to provide the Canadian and international markets with first-rate medicinal and recreational cannabis. To achieve its goal, Terranueva implements a modular production approach, integrating the latest advances and innovations in process automation. Terranueva Pharma Corporation, its wholly owned subsidiary, holds the necessary licences from Health Canada to accomplish its mission.

The Canadian Securities Exchange (CSE) has not in any way passed upon the merits of the anticipated operation and has neither approved nor disapproved the contents of this press release.

Neither the Canadian Securities Exchange (CSE) nor its Regulation Services Providers (as that term is defined in its policies) accept responsibility for the adequacy or accuracy of this press release.

For more information, please contact:

For Terranueva Corporation:

Dominique St-Louis
Chief Financial Officer
Telephone: 514.573.9066


Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today